{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T06:28:08Z","timestamp":1794119288606,"version":"4.8.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jad.2026.121372","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T17:12:30Z","timestamp":1770657150000},"page":"121372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Electroconvulsive therapy, BDNF and major depressive disorder: A meta-analysis with biological subgroups and clinical assessment of outcomes"],"prefix":"10.1016","volume":"404","author":[{"given":"Arleise Nunes Cavalcanti de","family":"Albuquerque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Alexandra da Silva Moita","family":"Minervino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S\u00e9rgio de Almeida","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma Vict\u00f3ria de Sales","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeoacaz Vitor Alves","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.121372_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1251882","article-title":"Beyond the surface: analyzing etomidate and propofol as anesthetic agents in electroconvulsive therapy \u2014 a systematic review and meta-analysis of seizure duration outcomes","volume":"14","author":"Akhtar","year":"2023","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.jad.2026.121372_bb0010","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1176\/appi.ajp.159.2.331","article-title":"The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging (task force report)","volume":"159","author":"American Psychiatric Association","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121372_bb0015","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2022"},{"issue":"2","key":"10.1016\/j.jad.2026.121372_bb0020","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1677\/JOE-07-0376","article-title":"Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm","volume":"197","author":"Begliuomini","year":"2008","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.jad.2026.121372_bb0030","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","article-title":"BDNF \u2013 a key transducer of antidepressant effects","volume":"102","author":"Bj\u00f6rkholm","year":"2016","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.jad.2026.121372_bb0035","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.euroneuro.2006.04.010","article-title":"Electroconvulsive therapy increases serum brain-derived neurotrophic factor in drug-resistant depressed patients","volume":"16","author":"Bocchio-Chiavetto","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.121372_bb0040","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1038\/npp.2016.86","article-title":"Relationship between hippocampal volume, serum BDNF, and depression severity following electroconvulsive therapy in late-life depression","volume":"41","author":"Bouckaert","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2026.121372_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e39278","article-title":"The link between BDNF and platelets in neurological disorders","volume":"10","author":"Bouhaddou","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jad.2026.121372_bb0050","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1017\/S1461145708009309","article-title":"A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression","volume":"11","author":"Brunoni","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.121372_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.214","article-title":"The human BDNF gene: peripheral gene expression and protein levels as biomarkers for psychiatric disorders","volume":"6","author":"Cattaneo","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2026.121372_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106060","article-title":"Inflammatory markers associated with electroconvulsive therapy response in patients with depression: a meta-analysis","volume":"170","author":"Dellink","year":"2025","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2026.121372_bb0070","article-title":"Effects of electroconvulsive therapy on inflammatory markers and depressive symptoms in adolescents with major depressive disorder","volume":"15","author":"Du","year":"2024","journal-title":"Front. Psychol."},{"issue":"3","key":"10.1016\/j.jad.2026.121372_bb0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neulet.2009.02.032","article-title":"Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug-resistant depressed patients","volume":"453","author":"Fernandes","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jad.2026.121372_bb0085","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.brainresbull.2016.02.013","article-title":"Remission of depression following electroconvulsive therapy (ECT) is associated with higher levels of brain-derived neurotrophic factor (BDNF)","volume":"121","author":"Freire","year":"2016","journal-title":"Brain Res. Bull."},{"issue":"7","key":"10.1016\/j.jad.2026.121372_bb0095","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jpsychires.2013.03.006","article-title":"Additional ECT increases BDNF levels in patients suffering from major depressive disorders compared to patients treated with citalopram only","volume":"47","author":"Haghighi","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2026.121372_bb0100","article-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2023"},{"key":"10.1016\/j.jad.2026.121372_bb0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbr.2017.12.025","article-title":"Understanding the pathophysiology of depression: from monoamines to the neurogenesis hypothesis model \u2013 are we there yet?","volume":"341","author":"Jesulola","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jad.2026.121372_bb0120","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1126\/science.1065057","article-title":"Regulation of cell survival by secreted proneurotrophins","volume":"294","author":"Lee","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jad.2026.121372_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2020.101983","article-title":"Brain-derived neurotrophic factor blood levels after electroconvulsive therapy in patients with major depressive disorder: a systematic review and meta-analysis","volume":"51","author":"Luan","year":"2020","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.jad.2026.121372_bb5000","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jclinepi.2019.12.002","article-title":"Consideration of confounding was suboptimal in the reporting of observational studies in psychiatry: A meta-epidemiological study","volume":"119","author":"Munkholm","year":"2020","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2026.121372_bb0140","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2026.121372_bb0155","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jad.2014.11.044","article-title":"BDNF as a biomarker for successful treatment of mood disorders: a systematic and quantitative meta-analysis","volume":"174","author":"Polyakova","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121372_bb0160","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3892\/etm.2021.10565","article-title":"Neuroplasticity and depression: rewiring the brain\u2019s networks through pharmacological therapy (review)","volume":"22","author":"R\u0103dulescu","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.jad.2026.121372_bb0165","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.psychres.2015.04.009","article-title":"Electroconvulsive therapy improves clinical manifestations of treatment-resistant depression without changing serum BDNF levels","volume":"227","author":"Rapinesi","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2026.121372_bb0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpsychires.2016.08.004","article-title":"Increased BDNF levels after electroconvulsive therapy in patients with major depressive disorder: a meta-analysis study","volume":"83","author":"Rocha","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2026.121372_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2014.12.018","article-title":"The international study to predict optimized treatment in depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment","volume":"61","author":"Saveanu","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2026.121372_bb0190","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/s41380-021-01381-x","article-title":"A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials","volume":"27","author":"Sforzini","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2026.121372_bb0195","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.jagp.2013.11.004","article-title":"Hippocampus atrophy and the longitudinal course of late-life depression","volume":"22","author":"Taylor","year":"2013","journal-title":"Am. J. Geriatr. Psychiatr."},{"issue":"5","key":"10.1016\/j.jad.2026.121372_bb0200","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/acps.12721","article-title":"The mortality rate of electroconvulsive therapy: a systematic review and pooled analysis","volume":"135","author":"T\u00f8rring","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"issue":"9360","key":"10.1016\/j.jad.2026.121372_bb0205","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(03)12705-5","article-title":"Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis","volume":"361","author":"UK ECT Review Group","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jad.2026.121372_bb0210","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41398-019-0491-9","article-title":"Brain-derived neurotrophic factor as a possible predictor of electroconvulsive therapy outcome","volume":"9","author":"Van Zutphen","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2026.121372_bb0215","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.brs.2019.02.015","article-title":"Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression","volume":"12","author":"Vanicek","year":"2019","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jad.2026.121372_bb0220","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.jad.2026.121372_bb0225","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.genhosppsych.2023.04.015","article-title":"Brain-derived neurotrophic factor blood levels after electroconvulsive therapy in patients with mental disorders: a systematic review and meta-analysis","volume":"83","author":"Wang","year":"2023","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jad.2026.121372_bb0230","doi-asserted-by":"crossref","first-page":"II6","DOI":"10.1007\/BF03035120","article-title":"Standardizing the Hamilton depression rating scale: past, present, and future","volume":"251 Suppl 2","author":"Williams","year":"2001","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2026.121372_bb0235","article-title":"World mental health report: transforming mental health for all","author":"World Health Organization","year":"2022","journal-title":"World Health Organization."},{"key":"10.1016\/j.jad.2026.121372_bb0240","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fncel.2020.00082","article-title":"The role of BDNF on neural plasticity in depression","volume":"14","author":"Yang","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jad.2026.121372_bb0245","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbi.2024.08.048","article-title":"The inflammatory underpinning of depression: an historical perspective","volume":"122","author":"Yirmiya","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2026.121372_bb0250","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jad.2013.03.002","article-title":"Upregulation of blood proBDNF and its receptors in major depression","volume":"150","author":"Zhou","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121372_bb0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.brainresbull.2014.04.005","article-title":"Effects of electroconvulsive therapy on serum levels of brain-derived neurotrophic factor and nerve growth factor in treatment-resistant major depression","volume":"104","author":"Bilgen","year":"2014","journal-title":"Brain Res. Bull."},{"issue":"3","key":"10.1016\/j.jad.2026.121372_bb0055","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00406-014-0543-3","article-title":"Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients","volume":"265","author":"Bumb","year":"2015","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2026.121372_bb0090","first-page":"12","article-title":"Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression","volume":"3","author":"Gedge","year":"2012","journal-title":"Front. Psychol."},{"issue":"2","key":"10.1016\/j.jad.2026.121372_bb0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/YCT.0b013e3181c18bbf","article-title":"The level of serum brain-derived neurotrophic factor is associated with the therapeutic efficacy of modified electroconvulsive therapy in Chinese patients with depression","volume":"26","author":"Hu","year":"2010","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2026.121372_bb0115","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neulet.2019.04.023","article-title":"Association between the novel seizure quality index for outcome prediction in electroconvulsive therapy and brain-derived neurotrophic factor serum levels","volume":"704","author":"Kranaster","year":"2019","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.jad.2026.121372_bb0125","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000352013","article-title":"Electroconvulsive therapy improves clinical manifestation with plasma BDNF levels unchanged in treatment-resistant depression patients","volume":"68","author":"Lin","year":"2013","journal-title":"Neuropsychobiology"},{"issue":"5","key":"10.1016\/j.jad.2026.121372_bb0135","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.pnpbp.2008.02.009","article-title":"Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study","volume":"32","author":"Okamoto","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.jad.2026.121372_bb0145","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3390\/brainsci13101358","article-title":"Changes in adipokine, resistin, and BDNF concentrations in treatment-resistant depression after electroconvulsive therapy","volume":"13","author":"Permoda-Pachuta","year":"2023","journal-title":"Brain Sci."},{"issue":"5","key":"10.1016\/j.jad.2026.121372_bb0150","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.euroneuro.2009.01.002","article-title":"Plasma brain-derived neurotrophic factor in treatment-resistant depressed patients receiving electroconvulsive therapy","volume":"19","author":"Piccinni","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.jad.2026.121372_bb0175","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.brs.2018.05.011","article-title":"BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy","volume":"11","author":"Ryan","year":"2018","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jad.2026.121372_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2016.01.012","article-title":"Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder","volume":"76","author":"Salehi","year":"2016","journal-title":"J. Psychiatr. Res."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726002235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726002235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T10:01:05Z","timestamp":1773136865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726002235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":50,"alternative-id":["S0165032726002235"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.121372","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electroconvulsive therapy, BDNF and major depressive disorder: A meta-analysis with biological subgroups and clinical assessment of outcomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.121372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121372"}}